$390.29
110.38[39.43%]
At close: May 10
$390.29
0[0.00%]
PreMarket: 9:24AM EDT
Bio-Rad Laboratories, Inc. Class B Common Stock
(NYSE:BIO/B)Bio-Rad Laboratories, Inc. Class B Common Stock Stock (NYSE:BIO/B), Quotes and News Summary
Bio-Rad Laboratories, Inc. Class B Common Stock Stock (NYSE: BIO/B) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / - |
| Day Range | - - - |
| 52 Wk Range | - - - |
| Market Cap | - |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NYSE |
| RSI | 0 |
| Short Interest | - |
| Days to Cover | - |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
N/A
Industry
N/A
Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnosti...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
You can purchase shares of Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO/B) through any online brokerage.
Who are Bio-Rad Laboratories, Inc. Class B Common Stock's (BIO/B) competitors?
Other companies in Bio-Rad Laboratories, Inc. Class B Common Stock’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
What is the target price for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
The latest price target for Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO/B) was reported by Citigroup on Wednesday, April 3, 2024. The analyst firm set a price target for 365.00 expecting BIO/B to fall to within 12 months (a possible -6.48% downside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B)?
The stock price for Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO/B) is $390.29 last updated May 10, 2023 at 9:24 AM EDT.
Does Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) pay a dividend?
A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
When is Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) reporting earnings?
Bio-Rad Laboratories, Inc. Class B Common Stock’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
Is Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) going to split?
There is no upcoming split for Bio-Rad Laboratories, Inc. Class B Common Stock.